IRIS ACQUISITION CORP (IRAA)

IRIS ACQUISITION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

IRIS ACQUISITION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - IssueWire

IRAA Makes Notable Cross Below Critical Moving Average

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

/PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies...

Iris Acquisition to combine with Liminatus Pharma (NASDAQ:IRAA)

Liminatus Pharma LLC and Iris Acquisition (IRAA) have entered into a definitive business combination pact

Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments